"we are calling for the immediate implementation of a statutory duty of candour for the health trusts."
.
.
.
of all car-t cell trials registered since 2001, more than half are being conducted in china.
.executive director of saen michael budkie made these reports public in a letter addressed to chancellor carol christ on wednesday
.